Cargando…
Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
BACKGROUND: The performance of liver stiffness measurements (LSMs) obtained using FibroScan can be affected by several factors, and cut-off values are different for fibrosis caused by various aetiologies. The study aims to evaluate the diagnostic accuracy of LSM in nonalcoholic fatty liver disease (...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986416/ https://www.ncbi.nlm.nih.gov/pubmed/33757528 http://dx.doi.org/10.1186/s12944-021-01453-5 |
_version_ | 1783668440547983360 |
---|---|
author | Yang, Xinyu Chang, Xinxia Wu, Shengdi Sun, Xiaoyang Zhu, Xiaopeng Wang, Liu Xu, Yushan Yao, Xiuzhong Rao, Shengxiang Hu, Xiqi Xia, Mingfeng Bian, Hua Yan, Hongmei Gao, Xin |
author_facet | Yang, Xinyu Chang, Xinxia Wu, Shengdi Sun, Xiaoyang Zhu, Xiaopeng Wang, Liu Xu, Yushan Yao, Xiuzhong Rao, Shengxiang Hu, Xiqi Xia, Mingfeng Bian, Hua Yan, Hongmei Gao, Xin |
author_sort | Yang, Xinyu |
collection | PubMed |
description | BACKGROUND: The performance of liver stiffness measurements (LSMs) obtained using FibroScan can be affected by several factors, and cut-off values are different for fibrosis caused by various aetiologies. The study aims to evaluate the diagnostic accuracy of LSM in nonalcoholic fatty liver disease (NAFLD) patients with abnormal glucose metabolism and investigate whether the LSM value would be affected by metabolic indicators. METHODS: The study involved 91 NAFLD patients with abnormal glucose metabolism who underwent liver biopsy. The diagnostic accuracy of LSM value was evaluated by the receiver operator characteristic (ROC) curves, with the biopsy results taken as the gold standard. Multivariate linear regression and subgroup analysis were performed to determine the correlated indicators. RESULTS: The areas under the ROC curves (AUROCs) of LSM values for detecting fibrosis stage ≥1, 2, 3 and 4 were 0.793 (95% confidence interval [CI]: 0.695–0.871), 0.764 (95% CI: 0.663–0.846), 0.837 (95% CI: 0.744–0.906) and 0.902 (95% CI: 0.822–0.955), with cut-off values of 6.3, 7.6, 8.3 and 13.8 kPa, respectively. Multivariate linear regression demonstrated that haemoglobin A1c (HbA1c, β = 0.205, P = 0.026) and alanine aminotransferase (ALT, β = 0.192, P = 0.047) were independently associated with the LSM value after adjustment for fibrosis stage, ballooning and inflammation grade from liver biopsy. Subgroup analysis demonstrated that LSM values were slightly higher in patients with HbA1c ≥7% than in those with HbA1c < 7% and in patients with body mass index (BMI) ≥30 kg/m(2) than in those with BMI < 30 kg/m(2). CONCLUSIONS: FibroScan was valuable for the evaluation of liver fibrosis in NAFLD patients with abnormal glucose metabolism. FibroScan is recommended to evaluate severe fibrosis, especially to exclude advanced fibrosis. Glucose metabolism state may affect LSM values. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01453-5. |
format | Online Article Text |
id | pubmed-7986416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79864162021-03-24 Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease Yang, Xinyu Chang, Xinxia Wu, Shengdi Sun, Xiaoyang Zhu, Xiaopeng Wang, Liu Xu, Yushan Yao, Xiuzhong Rao, Shengxiang Hu, Xiqi Xia, Mingfeng Bian, Hua Yan, Hongmei Gao, Xin Lipids Health Dis Research BACKGROUND: The performance of liver stiffness measurements (LSMs) obtained using FibroScan can be affected by several factors, and cut-off values are different for fibrosis caused by various aetiologies. The study aims to evaluate the diagnostic accuracy of LSM in nonalcoholic fatty liver disease (NAFLD) patients with abnormal glucose metabolism and investigate whether the LSM value would be affected by metabolic indicators. METHODS: The study involved 91 NAFLD patients with abnormal glucose metabolism who underwent liver biopsy. The diagnostic accuracy of LSM value was evaluated by the receiver operator characteristic (ROC) curves, with the biopsy results taken as the gold standard. Multivariate linear regression and subgroup analysis were performed to determine the correlated indicators. RESULTS: The areas under the ROC curves (AUROCs) of LSM values for detecting fibrosis stage ≥1, 2, 3 and 4 were 0.793 (95% confidence interval [CI]: 0.695–0.871), 0.764 (95% CI: 0.663–0.846), 0.837 (95% CI: 0.744–0.906) and 0.902 (95% CI: 0.822–0.955), with cut-off values of 6.3, 7.6, 8.3 and 13.8 kPa, respectively. Multivariate linear regression demonstrated that haemoglobin A1c (HbA1c, β = 0.205, P = 0.026) and alanine aminotransferase (ALT, β = 0.192, P = 0.047) were independently associated with the LSM value after adjustment for fibrosis stage, ballooning and inflammation grade from liver biopsy. Subgroup analysis demonstrated that LSM values were slightly higher in patients with HbA1c ≥7% than in those with HbA1c < 7% and in patients with body mass index (BMI) ≥30 kg/m(2) than in those with BMI < 30 kg/m(2). CONCLUSIONS: FibroScan was valuable for the evaluation of liver fibrosis in NAFLD patients with abnormal glucose metabolism. FibroScan is recommended to evaluate severe fibrosis, especially to exclude advanced fibrosis. Glucose metabolism state may affect LSM values. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01453-5. BioMed Central 2021-03-23 /pmc/articles/PMC7986416/ /pubmed/33757528 http://dx.doi.org/10.1186/s12944-021-01453-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Yang, Xinyu Chang, Xinxia Wu, Shengdi Sun, Xiaoyang Zhu, Xiaopeng Wang, Liu Xu, Yushan Yao, Xiuzhong Rao, Shengxiang Hu, Xiqi Xia, Mingfeng Bian, Hua Yan, Hongmei Gao, Xin Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease |
title | Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease |
title_full | Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease |
title_fullStr | Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease |
title_full_unstemmed | Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease |
title_short | Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease |
title_sort | performance of liver stiffness measurements obtained with fibroscan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986416/ https://www.ncbi.nlm.nih.gov/pubmed/33757528 http://dx.doi.org/10.1186/s12944-021-01453-5 |
work_keys_str_mv | AT yangxinyu performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease AT changxinxia performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease AT wushengdi performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease AT sunxiaoyang performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease AT zhuxiaopeng performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease AT wangliu performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease AT xuyushan performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease AT yaoxiuzhong performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease AT raoshengxiang performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease AT huxiqi performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease AT xiamingfeng performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease AT bianhua performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease AT yanhongmei performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease AT gaoxin performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease |